Work

Abstract 1201: The PLK4 inhibitor RP-1664 drives centriole modulation and single agent tumor regressions in preclinical neuroblastoma models

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-1201

Authors: Minu Samanta, Daivd Groff, Isabel Soria-Bretones, Joanna Li, Parham Nejad, Elliot Goodfellow, Alvin Farrel, Khushbu Patel, Kateryna Krytska, Steven B. Neuhauser, Timothy M. Stearns, Yael P. Mossé, JD Schonhoft, Marc L. Hyer, Michal Zimmermann, Gary Marshall, John M. Maris

Institutions: Children's Hospital of Philadelphia, Jackson Laboratory

Language: English

Topic: Neuroblastoma Research and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409690248

Cites:

Cited by:

Related to: 10